These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2395882)

  • 1. Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization.
    Fawell SE; White R; Hoare S; Sydenham M; Page M; Parker MG
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6883-7. PubMed ID: 2395882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells.
    Reese JC; Katzenellenbogen BS
    Nucleic Acids Res; 1991 Dec; 19(23):6595-602. PubMed ID: 1754396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogens activate an estrogen receptor mutant exhibiting enhanced binding to the estrogen response element.
    Xing H; Haase S; Shapiro DJ
    Biochem Biophys Res Commun; 1994 Jul; 202(2):888-95. PubMed ID: 8048961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.
    Chen D; Pace PE; Coombes RC; Ali S
    Mol Cell Biol; 1999 Feb; 19(2):1002-15. PubMed ID: 9891036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.
    Mahfoudi A; Roulet E; Dauvois S; Parker MG; Wahli W
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4206-10. PubMed ID: 7753783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor.
    Zajchowski DA; Webster L; Humm R; White FA; Simmons SJ; Bartholdi M
    J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):373-83. PubMed ID: 9449240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling.
    Dauvois S; White R; Parker MG
    J Cell Sci; 1993 Dec; 106 ( Pt 4)():1377-88. PubMed ID: 8126115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue.
    Gibson MK; Nemmers LA; Beckman WC; Davis VL; Curtis SW; Korach KS
    Endocrinology; 1991 Oct; 129(4):2000-10. PubMed ID: 1915080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nuclear transport is not essential for inhibition of receptor function by the type II estrogen antagonist ICI-164,384.
    Miksicek RJ; Lee C; Topp-Rapiejko K; Neff S
    Ann N Y Acad Sci; 1995 Jun; 761():361-4. PubMed ID: 7625736
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of antihormone action.
    Gronemeyer H; Benhamou B; Berry M; Bocquel MT; Gofflo D; Garcia T; Lerouge T; Metzger D; Meyer ME; Tora L
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):217-21. PubMed ID: 1562505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.
    Dauvois S; Danielian PS; White R; Parker MG
    Proc Natl Acad Sci U S A; 1992 May; 89(9):4037-41. PubMed ID: 1570330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
    Elgort MG; Zou A; Marschke KB; Allegretto EA
    Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ligand binding and DNA binding on the structure of the mouse oestrogen receptor.
    Emmas CE; Fawell SE; Hoare SA; Parker MG
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):291-9. PubMed ID: 1562507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Action of "pure" antiestrogens in inhibiting estrogen receptor action.
    Parker MG
    Breast Cancer Res Treat; 1993; 26(2):131-7. PubMed ID: 8219250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen.
    Howell A; Osborne CK; Morris C; Wakeling AE
    Cancer; 2000 Aug; 89(4):817-25. PubMed ID: 10951345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-estrogen activity in the yeast transcription system: estrogen receptor mediated agonist response.
    Kohno H; Gandini O; Curtis SW; Korach KS
    Steroids; 1994 Oct; 59(10):572-8. PubMed ID: 7878684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness.
    Thompson EW; Katz D; Shima TB; Wakeling AE; Lippman ME; Dickson RB
    Cancer Res; 1989 Dec; 49(24 Pt 1):6929-34. PubMed ID: 2582435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of proteins with transcriptionally active estrogen receptors.
    Cavaillès V; Dauvois S; Danielian PS; Parker MG
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10009-13. PubMed ID: 7937828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.